Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Clinical Immunology (Orlando, Fla.)|November 10, 2015
Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40Junxiang Wang, Lu Wang, Ying Xiang, et al.
Advances in Experimental Medicine and Biology|September 20, 2012
Complement in Action: An Analysis of Patent Trends from 1976 Through 2011Kun Yang, Robert A Deangelis, Janet E Reed, et al.
Protein Science : a Publication of the Protein Society|August 9, 2008
Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3dNurit Haspel, Daniel Ricklin, Brian V Geisbrecht, et al.
Nature Reviews. Immunology|September 19, 2017
Complement in cancer: untangling an intricate relationshipEdimara S Reis, Dimitrios C Mastellos, Daniel Ricklin, et al.
Nature Immunology|November 17, 2017
Novel mechanisms and functions of complementGeorge Hajishengallis, Edimara S Reis, Dimitrios C Mastellos, et al.
Immunological Reviews|October 27, 2016
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defenseDaniel Ricklin, Edimara S Reis, Dimitrios C Mastellos, et al.
Trends in Immunology|April 19, 2017
Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based DiscoveryDimitrios C Mastellos, Edimara S Reis, Daniel Ricklin, et al.
Advances in Experimental Medicine and Biology|September 28, 2011
Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteinsBrandon L Garcia, Kasra X Ramyar, Daniel Ricklin, et al.
Nature Immunology|March 14, 2007
A structural basis for complement inhibition by Staphylococcus aureusMichal Hammel, Georgia Sfyroera, Daniel Ricklin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2017
Structural Implications for the Formation and Function of the Complement Effector Protein iC3bMalvina Papanastasiou, Sophia Koutsogiannaki, Yiannis Sarigiannis, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Clinical Immunology (Orlando, Fla.)|November 10, 2015
Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40Junxiang Wang, Lu Wang, Ying Xiang, et al.
Advances in Experimental Medicine and Biology|September 20, 2012
Complement in Action: An Analysis of Patent Trends from 1976 Through 2011Kun Yang, Robert A Deangelis, Janet E Reed, et al.
Protein Science : a Publication of the Protein Society|August 9, 2008
Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3dNurit Haspel, Daniel Ricklin, Brian V Geisbrecht, et al.
Nature Reviews. Immunology|September 19, 2017
Complement in cancer: untangling an intricate relationshipEdimara S Reis, Dimitrios C Mastellos, Daniel Ricklin, et al.
Nature Immunology|November 17, 2017
Novel mechanisms and functions of complementGeorge Hajishengallis, Edimara S Reis, Dimitrios C Mastellos, et al.
Immunological Reviews|October 27, 2016
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defenseDaniel Ricklin, Edimara S Reis, Dimitrios C Mastellos, et al.
Trends in Immunology|April 19, 2017
Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based DiscoveryDimitrios C Mastellos, Edimara S Reis, Daniel Ricklin, et al.
Advances in Experimental Medicine and Biology|September 28, 2011
Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteinsBrandon L Garcia, Kasra X Ramyar, Daniel Ricklin, et al.
Nature Immunology|March 14, 2007
A structural basis for complement inhibition by Staphylococcus aureusMichal Hammel, Georgia Sfyroera, Daniel Ricklin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2017
Structural Implications for the Formation and Function of the Complement Effector Protein iC3bMalvina Papanastasiou, Sophia Koutsogiannaki, Yiannis Sarigiannis, et al.
Pageof 14